- Home
- BTAI vs EEIQ Comparison
BTAI vs EEIQ Comparison
Compare BTAI & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- EEIQ
- Stock Information
- Founded
- BTAI 2017
- EEIQ 2017
- Country
- BTAI United States
- EEIQ United States
- Employees
- BTAI N/A
- EEIQ N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- EEIQ Other Consumer Services
- Sector
- BTAI Health Care
- EEIQ Real Estate
- Exchange
- BTAI Nasdaq
- EEIQ Nasdaq
- Market Cap
- BTAI 8.4M
- EEIQ 9.5M
- IPO Year
- BTAI 2018
- EEIQ 2021
- Fundamental
- Price
- BTAI $1.84
- EEIQ $0.54
- Analyst Decision
- BTAI Buy
- EEIQ
- Analyst Count
- BTAI 5
- EEIQ 0
- Target Price
- BTAI $42.60
- EEIQ N/A
- AVG Volume (30 Days)
- BTAI 436.1K
- EEIQ 3.5K
- Earning Date
- BTAI 08-05-2025
- EEIQ 07-14-2025
- Dividend Yield
- BTAI N/A
- EEIQ N/A
- EPS Growth
- BTAI N/A
- EEIQ N/A
- EPS
- BTAI N/A
- EEIQ N/A
- Revenue
- BTAI $1,852,000.00
- EEIQ $8,153,546.00
- Revenue This Year
- BTAI $5.03
- EEIQ N/A
- Revenue Next Year
- BTAI $291.01
- EEIQ N/A
- P/E Ratio
- BTAI N/A
- EEIQ N/A
- Revenue Growth
- BTAI 5.47
- EEIQ 42.73
- 52 Week Low
- BTAI $1.17
- EEIQ $0.44
- 52 Week High
- BTAI $25.92
- EEIQ $1.19
- Technical
- Relative Strength Index (RSI)
- BTAI 64.53
- EEIQ 35.85
- Support Level
- BTAI $1.17
- EEIQ $0.60
- Resistance Level
- BTAI $1.48
- EEIQ $0.67
- Average True Range (ATR)
- BTAI 0.13
- EEIQ 0.03
- MACD
- BTAI 0.06
- EEIQ -0.01
- Stochastic Oscillator
- BTAI 100.00
- EEIQ 0.00
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About EEIQ EpicQuest Education Group International Limited
EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.